ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 332,36
-0,83%
Dow Jones
42 392,27
0,00%
DAX
19 958,37
-0,23%
Brent Oil
75,85
-0,01%
Bitcoin
96 742,55
-0,16%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Danaher Corporation (DHR)

  7. Danaher Corporation (DHR) Actualités

DHR

Danaher (DHR)

Danaher Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:DHR
DateHeureSourceTitreSymboleSociété
02/01/202522h05PR Newswire (US)Danaher Schedules Fourth Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
19/12/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DHRDanaher Corporation
11/12/202413h49Edgar (US Regulatory)Form 8-K - Current reportNYSE:DHRDanaher Corporation
10/12/202422h15PR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
26/11/202423h00PR Newswire (US)Danaher to Present at Evercore ISI HealthCONx ConferenceNYSE:DHRDanaher Corporation
26/11/202422h40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DHRDanaher Corporation
08/11/202414h23Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:DHRDanaher Corporation
22/10/202412h00PR Newswire (US)Danaher Reports Third Quarter 2024 ResultsNYSE:DHRDanaher Corporation
27/09/202414h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:DHRDanaher Corporation
19/09/202422h30PR Newswire (US)Danaher Schedules Third Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
17/09/202414h30PR Newswire (US)Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term PartnershipNYSE:DHRDanaher Corporation
04/09/202422h30PR Newswire (US)Danaher Confirms Third Quarter and Full Year 2024 GuidanceNYSE:DHRDanaher Corporation
26/08/202423h30PR Newswire (US)Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C.NYSE:DHRDanaher Corporation
30/07/202413h30GlobeNewswire Inc.Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s DiseaseNYSE:DHRDanaher Corporation
25/07/202415h00PR Newswire (US)Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation CelebrationNYSE:DHRDanaher Corporation
23/07/202412h00PR Newswire (US)Danaher Reports Second Quarter 2024 ResultsNYSE:DHRDanaher Corporation
17/07/202413h30PR Newswire (US)Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine DevelopmentNYSE:DHRDanaher Corporation
16/07/202413h30PR Newswire (US)Danaher Releases 2024 Sustainability ReportNYSE:DHRDanaher Corporation
11/07/202413h30PR Newswire (US)Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug ScreeningNYSE:DHRDanaher Corporation
09/07/202409h00PR Newswire (US)Beckman Coulter Introduces New Integrated Chemistry and Immunoassay AnalyzerNYSE:DHRDanaher Corporation
24/06/202422h30PR Newswire (US)Danaher Schedules Second Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
19/06/202413h30PR Newswire (US)Danaher appoints Julie Sawyer Montgomery to Executive Vice President for DiagnosticsNYSE:DHRDanaher Corporation
05/06/202413h00PR Newswire (US)Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence OfficerNYSE:DHRDanaher Corporation
09/05/202413h00PR Newswire (US)Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological DiagnosisNYSE:DHRDanaher Corporation
07/05/202422h45PR Newswire (US)Danaher to Present at Bank of America Securities Healthcare ConferenceNYSE:DHRDanaher Corporation
03/05/202415h06PR Newswire (US)Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow CytometryNYSE:DHRDanaher Corporation
23/04/202412h00PR Newswire (US)Danaher Reports First Quarter 2024 ResultsNYSE:DHRDanaher Corporation
21/03/202421h15PR Newswire (US)Danaher Schedules First Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
27/02/202422h15PR Newswire (US)Danaher to Present at TD Cowen Health Care ConferenceNYSE:DHRDanaher Corporation
22/02/202422h15PR Newswire (US)Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction TargetsNYSE:DHRDanaher Corporation
 Showing the most relevant articles for your search:NYSE:DHR

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
EU
DG
Vinci
EU
HO
Thales
EU
GLE
Societe Generale
COIN
ADAUSD
Cardano
EU
AF
Air FranceKLM
EU
SGO
Cie de SaintGobain
COIN
DOGEUSD
Dogecoin
NYSE
MRK
Merck
NASDAQ
MSFT
Microsoft
EU
RNO
Renault
EU
BNP
BNP Paribas
EU
ACA
Credit Agricole
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés